NCT02675829 2026-03-04
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
RenJi Hospital
The Netherlands Cancer Institute
Tempus AI
The Methodist Hospital Research Institute
Sichuan Baili Pharmaceutical Co., Ltd.